By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Aromatase inhibitors > Letrozole > Letrozole Dosage
Aromatase inhibitors
https://themeditary.com/dosage-information/letrozole-dosage-6065.html

Letrozole Dosage

Drug Detail:Letrozole (Letrozole [ let-roe-zol ])

Drug Class: Aromatase inhibitors Hormones / antineoplastics

Contents
Uses Warnings Before Taking Dosage Side effects Interactions FAQ

Usual Adult Dose for Breast Cancer

2.5 mg orally once a day

Duration of therapy:

  • Adjuvant and extended adjuvant settings: Optimal duration is unknown; discontinue therapy at relapse.
  • Advanced disease: Until tumor progression is evident.

Uses:
  • Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer
  • Extended adjuvant treatment of early breast cancer in postmenopausal women who have received 5 years of adjuvant tamoxifen therapy
  • First-line treatment of advanced breast cancer in postmenopausal women with hormone receptor positive or unknown locally advanced or metastatic breast cancer; second-line treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy

Usual Adult Dose for Breast Cancer - Adjuvant

2.5 mg orally once a day

Duration of therapy:

  • Adjuvant and extended adjuvant settings: Optimal duration is unknown; discontinue therapy at relapse.
  • Advanced disease: Until tumor progression is evident.

Uses:
  • Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer
  • Extended adjuvant treatment of early breast cancer in postmenopausal women who have received 5 years of adjuvant tamoxifen therapy
  • First-line treatment of advanced breast cancer in postmenopausal women with hormone receptor positive or unknown locally advanced or metastatic breast cancer; second-line treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy

Renal Dose Adjustments

CrCl 10 mL/min or greater: No adjustment recommended.
CrCl less than 10 mL/min: Data not available

Liver Dose Adjustments

Mild to moderate hepatic impairment: No adjustment recommended.
Severe hepatic impairment with cirrhosis: 2.5 mg orally every other day
Noncirrhotic with elevated bilirubin: Data not available

Precautions

CONTRAINDICATIONS:

  • Hypersensitivity to the active component or any of the ingredients
  • Pregnancy

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

This drug is anticipated to be dialyzable; however, no dose adjustment guidelines have been reported.

Other Comments

Administration Advice:

  • Take this drug without regard to meals.
  • Use this drug only in women with clearly established postmenopausal status. In patients whose menopausal status is unclear, measure luteinizing hormone (LH), follicle-stimulating hormone (FSH) and/or estradiol levels before initiating treatment.
  • Skip a missed dose if it is within 2 or 3 hours of the next dose; otherwise, take the missed dose as soon as possible and then return to the regular dosing schedule.

Storage Requirements:
Store this drug at room temperature (20 to 25 Celsius) and protect from light.

General:
  • The clinical benefit of this drug in premenopausal women with breast cancer has not been determined.
  • Efficacy of this drug has not been demonstrated in patients with hormone receptor negative breast cancer.
  • Use of this drug in men with breast cancer has not been studied.
  • Specific treatment for overdosage is not known.

Monitoring:
  • Bone mineral density
  • Serum cholesterol

Patient Advice:
This drug may cause fatigue, dizziness, and drowsiness; avoid driving or any other potentially dangerous activity until you know how this drug affects you.

Frequently asked questions

  • How many cycles of letrozole are needed to get pregnant?
  • How long do letrozole side effects last?
  • When will I ovulate after taking letrozole?
  • What happens when you stop taking letrozole?
  • When is the best time of day to take letrozole?
  • How does Femara affect your period?
  • How do you take letrozole for fertility?
  • Is letrozole a form of chemotherapy?
  • Does Femara make your hair fall out?
  • When do you ovulate on Femara?
  • Can Femara cause twins?
  • Does letrozole affect blood sugar levels?
  • What is the success rate for Femara in breast cancer?
  • Which is better - Aromasin or Femara?
  • Aromasin vs Femara - how do they compare?
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by